Description

Prp (plasma rich thrombosite)

When all baby girls are born, there are around 2 million eggs in their ovaries, and this seemingly huge
storage drops to around 400,000 by the time of puberty. An average of 1000
eggs are lost each month, since the mid-30s, a significant deterioration is observed
in both the number of eggs and the quality of the eggs. Towards the middle
of the 40s, the ovarian stores will be reduced to almost no. This process
is a process that develops normally in the ovaries of women and the menopausal
period begins.
In a normal menstrual cycle, we observe a
certain number of eggs every month with ultrasound and one of them matures and
passes into the tube by cracking. This process is called ovulation. In a
30-year-old woman, one of every 2-3 eggs is correct in terms of chromosomal
structure, while this rate decreases to one in 5-6 eggs at the age of 40.

Egg drafts should be viewed ultrasonographically
in the ovaries in order to achieve pregnancy by normal means and to achieve
pregnancy in in vitro fertilization. Every egg that will develop at this
stage will have a significant contribution on pregnancy outcomes. At this
stage, it has come to the fore in the world that the PRP procedure may be
beneficial on ovarian stores in the last year.
”PRP” (Platelet Rich Plasma),

also known as Platelet Rich Plasma, is a method prepared from the person’s own blood
and used to stimulate and regulate healing in many areas of medicine. With
the help of dozens of PRP preparation kits in use, 10-60 ml of blood is taken
from the patient, this blood is separated with special disposable filters and
centrifuge devices and unwanted parts are removed. The 2-6 ml aliquot
contains PRP. The idea that the presence of some growth factors in this
serum can be beneficial when applied to the patient group with reduced ovarian
stores has come to the fore. For this purpose, injecting it into the ovary
can enable some cells in the ovaries to become active and take effect within a
few months after the procedure. Since there are very limited scientific
studies in the world, it is useful to be cautious about giving very clear
information about this method and making big promises to patients. However,
it should be kept in mind that ovarian activity can be achieved in a limited
number of data as a result of short-term applications in the world. For
this reason, this method, which is a promising treatment for the patient group
with reduced egg storage, has also been of interest to our clinic.